These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10343149)

  • 1. Posturographic findings in patients with idiopathic cervical dystonia before and after local injections with botulinum toxin.
    Wöber C; Schnider P; Steinhoff N; Trattnig S; Zebenholzer K; Auff E
    Eur Neurol; 1999; 41(4):194-200. PubMed ID: 10343149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin A for the treatment of cervical dystonia.
    Zesiewicz TA; Stamey W; Sullivan KL; Hauser RA
    Expert Opin Pharmacother; 2004 Sep; 5(9):2017-24. PubMed ID: 15330738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term remission of idiopathic cervical dystonia after treatment with botulinum toxin.
    Giladi N; Meer J; Kidan H; Honigman S
    Eur Neurol; 2000; 44(3):144-6. PubMed ID: 11053961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A.
    Brashear A; Ambrosius WT; Eckert GJ; Siemers ER
    Mov Disord; 1998 Jan; 13(1):158-61. PubMed ID: 9452343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin injections reduce associative plasticity in patients with primary dystonia.
    Kojovic M; Caronni A; Bologna M; Rothwell JC; Bhatia KP; Edwards MJ
    Mov Disord; 2011 Jun; 26(7):1282-9. PubMed ID: 21469207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of botulinum toxin injections for spasmodic torticollis of tardive dystonia.
    Kaufman DM
    J Neuropsychiatry Clin Neurosci; 1994; 6(1):50-3. PubMed ID: 8148637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The position of the head in space: a kinematic analysis in patients with cervical dystonia treated with botulinum toxin.
    Albani G; Bulgheroni MV; Mancini F; Mauro A; Fundarò C; Pacchetti C; Sandrini G; Nappi G
    Funct Neurol; 2001; 16(2):135-41. PubMed ID: 11495419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia.
    Lew MF; Adornato BT; Duane DD; Dykstra DD; Factor SA; Massey JM; Brin MF; Jankovic J; Rodnitzky RL; Singer C; Swenson MR; Tarsy D; Murray JJ; Koller M; Wallace JD
    Neurology; 1997 Sep; 49(3):701-7. PubMed ID: 9305326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cervical dystonia with botulinum toxin.
    Jankovic J
    Mov Disord; 2004 Mar; 19 Suppl 8():S109-15. PubMed ID: 15027062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin therapy for cervical dystonia.
    Walker FO
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):749-66, vi. PubMed ID: 14580035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Botulinum toxin in the treatment of focal dystonias: own experience with botulinum toxin].
    Stefanoff P; Kiliszek M; Friedman A
    Neurol Neurochir Pol; 2000; 34(1):61-70. PubMed ID: 10849905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type F for treatment of dystonia: long-term experience.
    Chen R; Karp BI; Hallett M
    Neurology; 1998 Nov; 51(5):1494-6. PubMed ID: 9818895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postural responses to vibration of neck muscles in patients with idiopathic torticollis.
    Lekhel H; Popov K; Anastasopoulos D; Bronstein A; Bhatia K; Marsden CD; Gresty M
    Brain; 1997 Apr; 120 ( Pt 4)():583-91. PubMed ID: 9153121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia.
    Dressler D; Paus S; Seitzinger A; Gebhardt B; Kupsch A
    J Neurol Neurosurg Psychiatry; 2013 Sep; 84(9):1014-9. PubMed ID: 23687362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse sensory geste in cervical dystonia.
    Asmus F; von Coelln R; Boertlein A; Gasser T; Mueller J
    Mov Disord; 2009 Jan; 24(2):297-300. PubMed ID: 19086084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.
    Mueller J
    Mov Disord; 2009 May; 24(7):1098-9; author reply 1100. PubMed ID: 18942082
    [No Abstract]   [Full Text] [Related]  

  • 19. Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A.
    Kanovský P; Streitová H; Dufek J; Znojil V; Daniel P; Rektor I
    Mov Disord; 1998 Jan; 13(1):108-17. PubMed ID: 9452335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and treatment of cervical and oromandibular dystonia in acutely brain-injured patients.
    Lo SE; Rosengart AJ; Novakovic RL; Kang UJ; Shah DN; Khan MA; Dalvi A; Goldenberg FD; Macdonald RL; Frank JI
    Neurocrit Care; 2005; 3(2):139-45. PubMed ID: 16174883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.